TL;DR: ๐ข Positive (pilot) โ low-dose clonidine infusion gave ~100 more minutes of sleep and better subjective quality in postoperative HDU patients, with no serious adverse events; cheaper alternative to dexmedetomidine.
1. Publication
- Title: Low-dose clonidine infusion to improve sleep in postoperative patients in the high-dependency unit. A randomised placebo-controlled single-centre trial
- Acronym: CLONES
- Year & Journal: Intensive Care Medicine, published September 23, 2024 (50(11):1873-1883)
- Citation: Liu D, Hallt E, Platz A, et al. Intensive Care Med. 2024;50(11):1873-1883. doi:10.1007/s00134-024-07619-w
2. Context & Rationale
Background: Dexmedetomidine improves sleep and reduces delirium postoperatively but is expensive and requires a monitored environment. Clonidine, another alpha2-agonist, is cheaper and already used safely on general wards, making it an attractive, more accessible alternative if effective for sleep promotion in postoperative high-dependency unit (HDU) patients.
Research Question/Hypothesis: In postoperative HDU patients, does low-dose clonidine infusion improve total sleep time compared with placebo?
3. Design & Methods
- Study Type: Double-blind, placebo-controlled, parallel-group pilot effectiveness RCT
- Setting & Centers: Single academic hospital, Australia (Royal Brisbane and Women's Hospital)
- Population: Adult elective non-cardiac surgery HDU patients (unit has sleep-promotion policies: nocturnal noise/light reduction, minimized nursing interventions)
- Intervention: Clonidine 0.3 ฮผg/kg/h IV, non-titrated, night of surgery
- Comparator: Saline placebo, same schedule
- Blinding: Double-blind
- Statistical Power & Follow-Up: Primary: total sleep time via consumer actigraphy/photoplethysmography device. 83 randomized, 80 in ITT analysis (39 clonidine, 41 placebo).
4. Key Results
80 patients analyzed (39 clonidine, 41 placebo).
Outcome | Clonidine | Placebo | Notes |
Total sleep time (primary) | ~100 minutes more | โ | Clonidine resulted in meaningfully more sleep |
Subjective sleep quality | Better | โ | Improved alongside quantity |
Delirium | 1 case pre-infusion, 0 by study end | โ | Very low incidence in this low-risk population; not a powered comparison |
Safety | 4 clonidine patients had drug ceased for bradycardia/hypotension (no additional treatment needed) | โ | No serious adverse events |
5. Internal Validity Assessment
Double-blind, placebo-controlled pilot effectiveness RCT with objective sleep measurement (actigraphy/photoplethysmography). Overall: Moderate โ rigorous blinding and objective outcome measurement for a pilot-scale trial; modest sample size (80 analyzed) is appropriate for a pilot effectiveness design but limits precision and power for secondary/safety outcomes.
6. External Validity Assessment
Single-center, low-risk elective non-cardiac surgery HDU population with existing sleep-promotion policies already in place โ an independent correspondence (Cao, Hu) specifically noted this may not represent higher-risk populations (ICU or emergency surgery patients).
7. Strengths & Limitations
Strengths: Double-blind, placebo-controlled design with objective sleep measurement; addresses a genuine, practical question (a cheaper alpha2-agonist alternative to dexmedetomidine) with direct cost/access implications.
Limitations: Single-center, pilot-scale trial in a low-risk population, per independent commentary (Cao, Hu, Intensive Care Med correspondence); assessed sleep quantity/quality only, not broader clinical outcomes; some patients required drug discontinuation for bradycardia/hypotension.
8. Interpretation & Practice Impact
Supports considering low-dose clonidine infusion as a cheaper, more widely accessible alternative to dexmedetomidine for improving postoperative sleep in HDU patients, in the context of existing non-pharmacological sleep-promotion measures โ though this is pilot-scale evidence requiring larger confirmatory trials before broad practice change.
9. Controversies & Subsequent Evidence
An independent correspondence (Cao S, Hu Y, "Postoperative sleep-improving effects of low-dose clonidine: reflections from a randomized controlled trial") specifically raised concerns about generalizability to higher-risk populations (ICU or emergency surgery patients) beyond this low-risk elective-surgery HDU cohort. A further correspondence ("Clonidine, dexmedetomidine, and postoperative sleep") continues this comparative discussion.
10. Summary & Executive Takeaway
Summary: CLONES, a double-blind, placebo-controlled pilot RCT, randomized 80 postoperative HDU patients to low-dose clonidine infusion or placebo. Clonidine resulted in approximately 100 minutes more total sleep time and better subjective sleep quality, with no serious adverse events (4 patients had drug ceased for bradycardia/hypotension without further treatment needed).
Overall Takeaway: Low-dose clonidine infusion meaningfully improves both sleep quantity and quality in postoperative HDU patients, offering a cheaper, more accessible alternative to dexmedetomidine for sleep promotion โ promising pilot-scale evidence, though independent commentary cautions against generalizing beyond this specific low-risk elective-surgery population without further confirmatory trials.
11. Bibliography
- Wang JG, Belley-Cรดtรฉ E, Burry L, et al. Clonidine for sedation in the critically ill: systematic review and meta-analysis. Crit Care. 2017;21(1):75.
- Cao S, Hu Y. Postoperative sleep-improving effects of low-dose clonidine: reflections from a RCT [correspondence]. Intensive Care Med. 2024. doi:10.1007/s00134-024-07680-5.